number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide GLP-1 Market Size, Share weight loss drug prescriptions semaglutide
Description
The SURMOUNT-5 trial demonstrated superior weight loss with tirzepatide compared to semaglutide at 72 weeks
10 This finding suggests that while the increase in prescriptions is partially attributable to disease burden, other influences are likely at play
Additional research is needed to further understand provider and patient behaviors underlying this broader trend
People feel supported, not just medicated
Prioritize protein at every meal
Even optimistic estimates, and these are truly generous projections, suggest sublingual bioavailability for a peptide of this molecular weight would fall well below 1%
